<DOC>
	<DOCNO>NCT02230527</DOCNO>
	<brief_summary>This single center , prospective , randomize , unblinded , open-label , active control pilot study evaluate efficacy safety ticagrelor plus aspirin versus clopidogrel plus aspirin patient Rutherford Stage IV VI PAD undergone percutaneous transluminal angioplasty ( PTA ) low extremity past 2 week .</brief_summary>
	<brief_title>Establishing Microcirculatory Effects Ticagrelor Tissue Perfusion Critical Limb Ischemia</brief_title>
	<detailed_description>Enrollment study require severe symptomatic CLI without wound ( Rutherford Stage IV ) CLI concomitant vascular insufficiency wound ( Rutherford Stage V-VI PAD ) . Potential participant identify screen prior discharge time first out-patient visit ( within 2 week discharge ) percutaneous low extremity arterial angiography arterial intervention ( stent balloon angioplasty ) presence low extremity vascular insufficiency . Participants classify Rutherford Class IV - VI ( without ulceration ) . A total 60 patient randomize 2 treatment group 1:1 ratio ( ticagrelor clopidogrel ) . Patients place clopidogrel arterial intervention per standard care . They remain clopidogrel time randomization occur . For patient randomize ticagrelor , clopidogrel stop . Patients randomize either ticagrelor 90mg mouth twice daily clopidogrel 75mg mouth daily .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>1 . Adults age 18100 year Rutherford Classification Stage IV VI PAD recent percutaneous low extremity arterial angiography arterial intervention past 2 week 2 . Willingness sign inform consent 3 . Ability return follow visit 4 . A female patient childbearing potential sexually active must agree use adequate contraception screen 30 day receive last dose study drug . Women childbearing potential define surgically sterilize ( hysterectomy , bilateral oophorectomy , tubal ligation ) post menopausal ( define least 2 year since last regular menses ) . The female patient lactate must negative pregnancy test screening . Patients ineligible study meet one follow criterion : 1 . Intolerance thienopyridines 2 . Hypersensitivity ticagrelor component product . 3 . Concomitant use oral anticoagulation vitamin K antagonist , factor Xa inhibitor , direct thrombin inhibitor 4 . History intracranial hemorrhage 5 . History severe hepatic impairment define baseline transaminase great equal 3x ULN elevation bilirubin 6 . Active bleed 7 . Allergy aspirin 8 . Baseline TcPO2 &lt; 10 mmHg post angiography 9 . Resting , pre procedure heart rate &lt; 50 beatsperminute without permanent pacemaker atrioventricular nodal block agent 10 . Severe COPD home oxygen therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>